Special Issue "The Role of Glycosaminoglycans in Human Diseases"
Deadline for manuscript submissions: 31 October 2023 | Viewed by 575
Glycosaminoglycans are one of the most important components of the extracellular matrix. As modulators of cell signaling, glycosaminoglycans are involved in the regulation of several processes that are important for the development and homeostasis of bone tissues, including proliferation, differentiation, adhesion, and migration of cells. The role of glycosaminoglycans in the above processes depends on their biochemical structure and the way these molecules are incorporated into the extracellular matrix as free polysaccharide chains or covalently bound in complexes with corresponding protein carriers (proteoglycans, glycoproteins). Accordingly, the structure and overall expression of glycosaminoglycans are tissue-specific and subject to dynamic changes during pathological events in the tissue (inflammation, infection, healing, regeneration). Exploiting different aspects of glycosaminoglycan biology holds great promise for the treatment of various human diseases.
We are pleased to publish original scientific papers or reviews that address the role of glycosaminoglycans, enzymes for glycosaminoglycan biosynthesis, modification, and degradation, and cell surface receptors for glycosaminoglycans in the pathogenesis of human diseases including inflammatory diseases, infectious diseases and cancer. Scientific papers dealing with the development of novel synthetic derivatives or therapeutics based on glycosaminoglycans and related factors for the treatment of experimental models (cell cultures, animal preparations, humans) with biomolecular experiments are also welcome. Purely clinical studies on the topic will not be suitable for this Special Issue.
The Article Processing Charge for publication in this open access journal is CHF 2900 (Swiss Francs) but the authors of papers submitted by the deadline will enjoy a favorable discount.
I cordially invite you to submit a paper to this Special Issue titled: “The Role of Glycosaminoglycans in Human Diseases”. Please, feel free to forward this invitation to your team members or colleagues who may also be interested in the topic.
Dr. Darko Kero
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- infectious disease